Brain Tumor Clinical Trials
Links shared publicly online about this topic
Clinical Trials for Brain Tumors in Tennessee
methodisthealth.or-live.com — “The Methodist Brain & Spine Institute in Tennessee conducts clinical trials designed to determine the safety and effectiveness of new brain tumor treatments.” View full resource at methodisthealth.or-live.com
Most Recently Shared on April 28, 2010 at 5:42 pm By:
The Memphis Regional Brain Tumor Center is currently conducting 2 clinical trials on Glioblastoma Multiforme: http://bit.ly/a45axi
Clinical Trial to Treat Brain Tumors with Electric Fields
physorg.com — “(PhysOrg.com) -- The University of Illinois at Chicago is taking part in an international, multi-center study for patients newly diagnosed with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM.” View full resource at physorg.com
Most Recently Shared on June 4, 2010 at 5:16 pm By:
Clinical Trial to Treat Brain Tumors with Electric Fields http://tw.physorg.com/194876151
Northwestern University Brain Tumor Institute - Research and Clinical Trials
braintumorinstitute.org — “Northwestern University Brain Tumor Institute - Research and Clinical Trials” View full resource at braintumorinstitute.org
Most Recently Shared on September 29, 2010 at 1:45 pm By:
Join the Brain Tumor Institute and special guest Bonnie Hunt for the 2nd annual Minds Matter gala on Oct. 6! http://bit.ly/9zOcCt
JFK Brain Tumor Center: First East Coast Site to Open Clinical Trial for Aggressive Brain Tumors
jfkmc.org — “JFK Brain Tumor Center: First East Coast Site to Open Clinical Trial for Aggressive Brain Tumors” View full resource at jfkmc.org
Most Recently Shared on February 20, 2012 at 4:55 pm By:
JFK Brain Tumor Center: First East Coast Site to Open Clinical Trial for Aggressive Brain Tumors Increasing the... http://t.co/Gm8xLLd6
Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
sciencedaily.com — “Researchers have launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalized vaccines -- produced from healthy and tumor cells from the patient him or herself -- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumors.” View full resource at sciencedaily.com
Most Recently Shared on December 2, 2009 at 1:40 am By:
Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines http://ow.ly/165S8C
Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
feeds.sciencedaily.com — “Researchers have launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalized vaccines -- produced from healthy and tumor cells from the patient him or herself -- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumors.” View full resource at feeds.sciencedaily.com
Most Recently Shared on December 1, 2009 at 9:27 pm By:
Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines: Researchers have... http://bit.ly/5oPda5
RTOG to Announce Initial Results of an International Phase III Clinical Trial for Newly Diagnosed Brain Tumors
newswise.com — “In the randomized trial, RTOG 0525 Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma, no significant improvement in overall patient survival or disease progression was observed for patients who received the dose-intensive (dose-dense) TMZ plus radiotherapy as compared to patients who received standard-dose TMZ plus radiotherapy. The trial did however prove the feasibility of collecting and analyzing tumor t” View full resource at newswise.com
Most Recently Shared on May 18, 2011 at 10:15 pm By:
RTOG to Announce Initial Results of an International Phase III Clinical Trial for Newly Diagnosed Brain ... http://bit.ly/kEJ1Q2 #cancer
New melanoma drug may shrink brain tumors
health.yahoo.net — “An experimental melanoma drug from GlaxoSmithKline managed to shrink secondary tumors in the brains of nine patients with advanced disease, according to results of a small clinical trial on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on October 10, 2010 at 9:48 am By:
New melanoma drug may shrink brain tumors http://bit.ly/dxkMnO
New melanoma drug may shrink brain tumors
health.yahoo.net — “An experimental melanoma drug from GlaxoSmithKline managed to shrink secondary tumors in the brains of nine patients with advanced disease, according to results of a small clinical trial on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on October 10, 2010 at 10:10 am By:
New melanoma drug may shrink brain tumors: An experimental melanoma drug from GlaxoSmithKline managed to shrink se... http://bit.ly/bxQzeO
Biomarker treatment for brain tumors studied
physorg.com — “The Brain Tumor Unit at the Moores UCSD Cancer Center at the University of California, San Diego, is launching a clinical trial that will examine the use of biomarkers to advance the treatment of malignant gliomas, brain tumors that start in the brain or spinal cord tissue. Annually, about 17,000 Americans ...” View full resource at physorg.com
Most Recently Shared on June 15, 2010 at 9:50 pm By:
Biomarker treatment for brain tumors studied http://tw.physorg.com/195840673
Researchers Prepare Clinical Trial That Will Use Fat-Enclosed Nanoparticles To Accurately Irradiate Brain Tumors
medicalnewstoday.com — “For the past 40 years, radiation has been the most effective method for treating deadly brain tumors called glioblastomas. But, although the targeting technology has been refined, beams of radiati” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2012 at 8:05 am By:
Researchers Prepare Clinical Trial That Will Use Fat-Enclosed Nanoparticles To Accurately Irradiate Brain Tumors... http://t.co/19vOb3NL
FDA approves first human neural stem cell clinical trial to treat brain tumors
physorg.com — “City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor. Karen S. Aboody, M.D., associate professor in City of Hope's ...” View full resource at physorg.com
Most Recently Shared on June 8, 2010 at 6:10 pm By:
FDA approves first human neural stem cell clinical trial to treat brain tumors http://tw.physorg.com/195221583
RTOG to Announce Initial Results of an International Phase III Clinical Trial for Newly Diagnosed Brain Tumors
newswise.com — “In the randomized trial, RTOG 0525 Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma, no significant improvement in overall patient survival or disease progression was observed for patients who received the dose-intensive (dose-dense) TMZ plus radiotherapy as compared to patients who received standard-dose TMZ plus radiotherapy. The trial did however prove the feasibility of collecting and analyzing tumor t” View full resource at newswise.com
Most Recently Shared on May 18, 2011 at 10:19 pm By:
RTOG to Announce Initial Results of an International Phase III Clinical Trial for Newly Diagnosed Brain Tumors: ... http://bit.ly/lVa1Mi
New melanoma drug may shrink brain tumors | Reuters
reuters.com — “MILAN (Reuters) - An experimental melanoma drug from GlaxoSmithKline managed to shrink secondary tumors in the brains of nine patients with advanced disease, according to results of a small clinical trial” View full resource at reuters.com
Most Recently Shared on October 10, 2010 at 9:30 am By:
New melanoma drug may shrink brain tumors http://reut.rs/bZ15RD
New melanoma drug may shrink brain tumors | Reuters
reuters.com — “MILAN (Reuters) - An experimental melanoma drug from GlaxoSmithKline managed to shrink secondary tumors in the brains of nine patients with advanced disease, according to results of a small clinical trial” View full resource at reuters.com
Most Recently Shared on October 10, 2010 at 10:22 am By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Methodist Healthcare
Providing high quality, cost-effective patient and family-centered care in Memphis, TN.
-
PhysOrg Health News
PhysOrg.com Health and Medicine News Stories
-
NU Feinberg Medicine
Northwestern University Feinberg School of Medicine: Educate, Discover, Improve Health.
Advertisement

